期刊文献+

视神经脊髓炎的发病机制 被引量:8

The Pathogensis of Neuromyelitis Optica
原文传递
导出
摘要 视神经脊髓炎免疫球蛋白G(NMO-Ig G)作用于水通道蛋白-4(AQP4),使AQP4含量减少并产生抗AQP4抗体。透过受损的血脑屏障,使NMO-Ig G进入中枢神经系统内,抗AQP4抗体损害了AQP4和Na+-依赖兴奋性氨基酸转运体复合物,引起谷氨酸兴奋性毒性和血脑屏障破坏。抗AQP4抗体通过细胞免疫毒性和补体依赖性细胞毒性、化学因素(过敏毒素如C3a、C5a)引起星形细胞损害。所有机制综合性损害血脑屏障,增加抗体,各种细胞(淋巴细胞和粒细胞)侵入中枢神经系统,造成视神经脊髓炎。 After the break down of aquaporin-4(AQP4) periperal tolerance leading to neuromyelitis optica immunoglobulin G (NMO-IgG)/anti-AQP4 antibody production, a beach in the blood-brain barriar (BBB), allows NMO-IgG to reach the CNS, bind AQP4 and induce pathogenic fuction. Anti-AQP4 antibodies induce the internalization of AQP4 and EAAT2 astrocyte proteins, and result in excitetoxicity, and increase BBB permeability. Anti-AQP4 antibodies can result in astrocyte injury by antibody dependent cellular cytotocity. Chemotactic factors such as anaphylatoxins C3a and C5a are released and induce the recruitment and activation of inlfammatory cells. All these mechanisms futher contribute to BBB disruption, enhancing antibody and cell entry to the CNS, and propagating NMO lesion formation.
作者 蒋雨平
出处 《中国临床神经科学》 2015年第3期321-323,共3页 Chinese Journal of Clinical Neurosciences
关键词 视神经脊髓炎 视神经脊髓炎免疫球蛋白G 水通道蛋白-4 发病机制 neuromyelitis optica neuromyelitis optica immunoglobulin G aquaporin-4 pathogenesis
  • 相关文献

参考文献8

  • 1Saikali P, Cayrol R, Vincent T. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica[J]. Autoimmun Rev,2009,9:132-135.
  • 2Lennon VA, Wingerchuk DM, Kryzer T J, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis[J]. Lancet,2004,364:2106-2112.
  • 3Vincent T, Saikali P, Cayrol R, et al. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment[J]. J Immunol,2008, 181:5730-5737.
  • 4Hinson SR, Roemer SF, Lucchinetti CF, et al. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2[J]. J Exp Med,2008,205:2473- 2481.
  • 5Hinson SR, Pittock S J, Lucchinetti CF, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica[J]. Neurology,2007,69:2221-2231.
  • 6Barnum SR, Szalai AJ. Complement and demyelinating disease: no MAC needed? [J]. Brain Res Rev,2006,52:58-68.
  • 7Spiller OB, Moretto G, Kim SU, et al. Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression[J]. J Neuroimmunol, 1996,71:97-106.
  • 8Harirchian MH, Tafakhori A, Taslimi S, et al. Seroprevalence of NMO- IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience[J]. Iran J Allergy Asthma Immunol,2015,14: 98 - 104.

同被引文献19

引证文献8

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部